Editorial
doi: 10.1002/cncr.22968.
18F-fluoro-2-deoxy-D-glucose-positron emission tomography (PET)/PET-computed tomography in carcinoma of the cervix
- PMID: 17763373
- DOI: 10.1002/cncr.22968
Item in Clipboard
Editorial
18F-fluoro-2-deoxy-D-glucose-positron emission tomography (PET)/PET-computed tomography in carcinoma of the cervix
Cancer.
.
Free article
No abstract available
Comment on
-
The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival.Cancer. 2007 Oct 15;110(8):1738-44. doi: 10.1002/cncr.22974. Cancer. 2007. PMID: 17786947
Similar articles
-
Preoperative lymph node staging of early-stage cervical carcinoma by [18F]-fluoro-2-deoxy-D-glucose-positron emission tomography.Cancer. 2005 Dec 1;104(11):2484-91. doi: 10.1002/cncr.21527. Cancer. 2005. PMID: 16270319
-
2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma.Cancer. 2004 Oct 15;101(8):1776-85. doi: 10.1002/cncr.20585. Cancer. 2004. PMID: 15386332
-
Value of dual-phase 2-fluoro-2-deoxy-d-glucose positron emission tomography in cervical cancer.J Clin Oncol. 2003 Oct 1;21(19):3651-8. doi: 10.1200/JCO.2003.01.102. J Clin Oncol. 2003. PMID: 14512397
-
[18F]-2-Fluoro-2-Deoxy-D-glucose-PET Assessment of Cervical Cancer.PET Clin. 2018 Apr;13(2):165-177. doi: 10.1016/j.cpet.2017.11.004. Epub 2018 Feb 3. PET Clin. 2018. PMID: 29482748 Free PMC article. Review.
-
Utility of positron emission tomography in sarcomas.Curr Opin Oncol. 2006 Jul;18(4):369-73. doi: 10.1097/01.cco.0000228744.49294.12. Curr Opin Oncol. 2006. PMID: 16721133 Review.
Cited by
-
Role of F-18 fluorodeoxyglucose positron emission tomography/computed tomography in the detection of recurrence in patients with cervical cancer.Indian J Nucl Med. 2013 Oct;28(4):216-20. doi: 10.4103/0972-3919.121966. Indian J Nucl Med. 2013. PMID: 24379531 Free PMC article.
-
Efficacy of 18F-FDG PET/CT in the evaluation of patients with recurrent cervical carcinoma.Eur J Nucl Med Mol Imaging. 2009 Dec;36(12):1952-9. doi: 10.1007/s00259-009-1206-x. Eur J Nucl Med Mol Imaging. 2009. PMID: 19585114 Free PMC article.
-
NEMA Performance Evaluation of CareMiBrain dedicated brain PET and Comparison with the whole-body and dedicated brain PET systems.Sci Rep. 2019 Oct 29;9(1):15484. doi: 10.1038/s41598-019-51898-z. Sci Rep. 2019. PMID: 31664096 Free PMC article.
